|
1
|
Siegel RL, Miller KD and Jemal A: Cancer
statistics, 2018. CA Cancer J Clin. 68:7–30. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Okura M, Aikawa T, Sawai NY, Iida S and
Kogo M: Decision analysis and treatment threshold in a management
for the N0 neck of the oral cavity carcinoma. Oral Oncol.
45:908–911. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Castilho RM, Squarize CH and Almeida LO:
Epigenetic modifications and head and neck cancer: Implications for
tumor progression and resistance to therapy. Int J Mol Sci.
18:15062017. View Article : Google Scholar
|
|
4
|
Kulkarni B, Kirave P, Gondaliya P, Jash K,
Jain A, Tekade RK and Kalia K: Exosomal miRNA in chemoresistance,
immune evasion, metastasis and progression of cancer. Drug Discov
Today. 24:2058–2067. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Ireland LV and Mielgo A: Macrophages and
fibroblasts, key players in cancer chemoresistance. Front Cell Dev
Biol. 6:1312018. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Senthebane DA, Rowe A, Thomford NE,
Shipanga H, Munro D, Al Mazeedi MAM, Almazyadi HAM, Kallmeyer K,
Dandara C, Pepper MS, et al: The role of tumor microenvironment in
chemoresistance: To survive, keep your enemies closer. Int J Mol
Sci. 18:15862017. View Article : Google Scholar
|
|
7
|
Chanmee T, Ontong P, Konno K and Itano N:
Tumor-associated macrophages as major players in the tumor
microenvironment. Cancers (Basel). 6:1670–1690. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Zhang X, Chen Y, Hao L, Hou A, Chen X, Li
Y, Wang R, Luo P, Ruan Z, Ou J, et al: Macrophages induce
resistance to 5-fluorouracil chemotherapy in colorectal cancer
through the release of putrescine. Cancer Lett. 381:305–313. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Yin Y, Yao S, Hu Y, Feng Y, Li M, Bian Z,
Zhang J, Qin Y, Qi X, Zhou L, et al: The immune-microenvironment
confers chemoresistance of colorectal cancer through
macrophage-derived IL6. Clin Cancer Res. 23:7375–7387. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Zheng P, Chen L, Yuan X, Luo Q, Liu Y, Xie
G, Ma Y and Shen L: Exosomal transfer of tumor-associated
macrophage-derived miR-21 confers cisplatin resistance in gastric
cancer cells. J Exp Clin Cancer Res. 36:532017. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Wei C, Yang C, Wang S, Shi D, Zhang C, Lin
X and Xiong B: M2 macrophages confer resistance to 5-fluorouracil
in colorectal cancer through the activation of CCL22/PI3K/AKT
signaling. Onco Targets Ther. 12:3051–3063. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Perrotta C, Cervia D, Di Renzo I, Moscheni
C, Bassi MT, Campana L, Martelli C, Catalani E, Giovarelli M,
Zecchini S, et al: Nitric oxide generated by tumor-associated
macrophages is responsible for cancer resistance to cisplatin and
correlated with syntaxin 4 and acid sphingomyelinase inhibition.
Front Immunol. 9:11862018. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Troiano G, Caponio VCA, Adipietro I,
Tepedino M, Santoro R, Laino L, Lo Russo L, Cirillo N and Lo Muzio
L: Prognostic significance of CD68+ and
CD163+ tumor associated macrophages in head and neck
squamous cell carcinoma: A systematic review and meta-analysis.
Oral Oncol. 93:66–75. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Kubota K, Moriyama M, Furukawa S, Rafiul
HASM, Maruse Y, Jinno T, Tanaka A, Ohta M, Ishiguro N, Yamauchi M,
et al: CD163+ CD204+ tumor-associated
macrophages contribute to T cell regulation via interleukin-10 and
PD-L1 production in oral squamous cell carcinoma. Sci Rep.
7:17552017. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Hu Y, He MY, Zhu LF, Yang CC, Zhou ML,
Wang Q, Zhang W, Zheng YY, Wang DM, Xu ZQ, et al: Tumor-associated
macrophages correlate with the clinicopathological features and
poor outcomes via inducing epithelial to mesenchymal transition in
oral squamous cell carcinoma. J Exp Clin Cancer Res. 35:122016.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Raposo G and Stoorvogel W: Extracellular
vesicles: Exosomes, microvesicles, and friends. J Cell Biol.
200:373–383. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Vlassov AV, Magdaleno S, Setterquist R and
Conrad R: Exosomes: Current knowledge of their composition,
biological functions, and diagnostic and therapeutic potentials.
Biochim Biophys Acta. 1820:940–948. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Mathivanan S, Ji H and Simpson RJ:
Exosomes: Extracellular organelles important in intercellular
communication. J Proteomics. 73:1907–1920. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Bang C and Thum T: Exosomes: New players
in cell-cell communication. Int J Biochem Cell Biol. 44:2060–2064.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Sento S, Sasabe E and Yamamoto T:
Application of a persistent heparin treatment inhibits the
malignant potential of oral squamous carcinoma cells induced by
tumor cell-derived exosomes. PLoS One. 11:e01484542016. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Osaki T, Tatemoto Y, Yoneda K and Yamamoto
T: Tumorigenicity of cell lines established from oral squamous cell
carcinoma and its metastatic lymph nodes. Eur J Cancer B Oral
Oncol. 30B:296–301. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Chanput W, Mes JJ and Wichers HJ: THP-1
cell line: An in vitro cell model for immune modulation approach.
Int Immunopharmacol. 23:37–45. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Daigneault M, Preston JA, Marriott HM,
Whyte MK and Dockrell DH: The identification of markers of
macrophage differentiation in PMA-stimulated THP-1 cells and
monocyte-derived macrophages. PLoS One. 5:e86682010. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Yin Z, Ma T, Huang B, Lin L, Zhou Y, Yan
J, Zou Y and Chen S: Macrophage-derived exosomal microRNA-501-3p
promotes progression of pancreatic ductal adenocarcinoma through
the TGFBR3-mediated TGF-β signaling pathway. J Exp Clin Cancer Res.
38:3102019. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Lan J, Sun L, Xu F, Liu L, Hu F, Song D,
Hou Z, Wu W, Luo X, Wang J, et al: M2 macrophage-derived exosomes
promote cell migration and invasion in colon cancer. Cancer Res.
79:146–158. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Zheng P, Luo Q, Wang W, Li J, Wang T, Wang
P, Chen L, Zhang P, Chen H, Liu Y, et al: Tumor-associated
macrophages-derived exosomes promote the migration of gastric
cancer cells by transfer of functional apolipoprotein E. Cell Death
Dis. 9:4342018. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Li X, Xu Q, Wu Y, Li J, Tang D, Han L and
Fan Q: A CCL2/ROS autoregulation loop is critical for
cancer-associated fibroblasts-enhanced tumor growth of oral
squamous cell carcinoma. Carcinogenesis. 35:1362–1370. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Wu MH, Hong HC, Hong TM, Chiang WF, Jin YT
and Chen YL: Targeting galectin-1 in carcinoma-associated
fibroblasts inhibits oral squamous cell carcinoma metastasis by
downregulating MCP-1/CCL2 expression. Clin Cancer Res.
17:1306–1316. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Quan J, Morrison NA, Johnson NW and Gao J:
MCP-1 as a potential target to inhibit the bone invasion by oral
squamous cell carcinoma. J Cell Biochem. 115:1787–1798. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Fujita S and Ikeda T: The CCL2-CCR2 axis
in lymph node metastasis from oral squamous cell carcinoma: An
immunohistochemical study. J Oral Maxillofac Surg. 75:742–749.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Ku WT, Tung JJ, Lee TJ and Lai KC:
Long-term exposure to Oroxylin A inhibits metastasis by suppressing
CCL2 in oral squamous cell carcinoma cells. Cancers (Basel).
11:E3532019. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Lu H, Wu B, Ma G, Zheng D, Song R, Huang
E, Mao M and Lu B: Melatonin represses oral squamous cell carcinoma
metastasis by inhibiting tumor-associated neutrophils. Am J Transl
Res. 9:5361–5374. 2017.PubMed/NCBI
|
|
33
|
Chen CH, Chuang HC, Lin YT, Fang FM, Huang
CC, Chen CM, Lu H and Chien CY: Circulating CD105 shows significant
impact in patients of oral cancer and promotes malignancy of cancer
cells via CCL20. Tumour Biol. 37:1995–2005. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Christofakis EP, Miyazaki H, Rubink DS and
Yeudall WA: Roles of CXCL8 in squamous cell carcinoma proliferation
and migration. Oral Oncol. 44:920–926. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Linton SS, Abraham T, Liao J, Clawson GA,
Butler PJ, Fox T, Kester M and Matters GL: Tumor-promoting effects
of pancreatic cancer cell exosomes on THP-1-derived macrophages.
PLoS One. 13:e02067592018. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Chen X, Zhou J, Li X and Wang X, Lin Y and
Wang X: Exosomes derived from hypoxic epithelial ovarian cancer
cells deliver microRNAs to macrophages and elicit a tumor-promoted
phenotype. Cancer Lett. 435:80–91. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Hsieh CH, Tai SK and Yang MH:
Snail-overexpressing cancer cells promote M2-like polarization of
tumor-associated macrophages by delivering MiR-21-abundant
exosomes. Neoplasia. 20:775–788. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Wang X, Luo G, Zhang K, Cao J, Huang C,
Jiang T, Liu B, Su L and Qiu Z: Hypoxic tumor-derived exosomal
miR-301a mediates M2 macrophage polarization via PTEN/PI3Kγ to
promote pancreatic cancer metastasis. Cancer Res. 78:4586–4598.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Wang F, Li B, Wei Y, Zhao Y, Wang L, Zhang
P, Yang J, He W, Chen H, Jiao Z and Li Y: Tumor-derived exosomes
induce PD1+ macrophage population in human gastric
cancer that promotes disease progression. Oncogenesis. 7:412018.
View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Piao YJ, Kim HS, Hwang EH, Woo J, Zhang M
and Moon WK: Breast cancer cell-derived exosomes and macrophage
polarization are associated with lymph node metastasis. Oncotarget.
9:7398–7410. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Namba T, Kodama R, Moritomo S, Hoshino T
and Mizushima T: Zidovudine, an anti-viral drug, resensitizes
gemcitabine-resistant pancreatic cancer cells to gemcitabine by
inhibition of the Akt-GSK3β-Snail pathway. Cell Death Dis.
6:e17952015. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Matsumoto T, Yokoi A, Hashimura M, Oguri
Y, Akiya M and Saegusa M: TGF-β-mediated LEFTY/Akt/GSK-3β/Snail
axis modulates epithelial-mesenchymal transition and cancer stem
cell properties in ovarian clear cell carcinomas. Mol Carcinog.
57:957–967. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Meng Q, Shi S, Liang C, Liang D, Hua J,
Zhang B, Xu J and Yu X: Abrogation of glutathione peroxidase-1
drives EMT and chemoresistance in pancreatic cancer by activating
ROS-mediated Akt/GSK3β/Snail signaling. Oncogene. 37:5843–5857.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Li D, Ji H, Niu X, Yin L, Wang Y, Gu Y,
Wang J, Zhou X, Zhang H and Zhang Q: Tumor-associated macrophages
secrete CC-chemokine ligand 2 and induce tamoxifen resistance by
activating PI3K/Akt/mTOR in breast cancer. Cancer Sci. 111:47–58.
2020. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Maolake A, Izumi K, Shigehara K,
Natsagdorj A, Iwamoto H, Kadomoto S, Takezawa Y, Machioka K,
Narimoto K, Namiki M, et al: Tumor-associated macrophages promote
prostate cancer migration through activation of the CCL22-CCR4
axis. Oncotarget. 8:9739–9751. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Kadomoto S, Izumi K, Hiratsuka K, Nakano
T, Naito R, Makino T, Iwamoto H, Yaegashi H, Shigehara K, Kadono Y,
et al: Tumor-associated macrophages induce migration of renal cell
carcinoma cells via activation of the CCL20-CCR6 axis. Cancers
(Basel). 12:892019. View Article : Google Scholar
|
|
47
|
Hosono M, Koma YI, Takase N, Urakawa N,
Higashino N, Suemune K, Kodaira H, Nishio M, Shigeoka M, Kakeji Y
and Yokozaki H: CXCL8 derived from tumor-associated macrophages and
esophageal squamous cell carcinomas contributes to tumor
progression by promoting migration and invasion of cancer cells.
Oncotarget. 8:106071–106088. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Iwase M, Yoshiba S, Uchid M, Takaoka S,
Kurihara Y, Ito D, Hatori M and Shintani S: Enhanced susceptibility
to apoptosis of oral squamous cell carcinoma cells subjected to
combined treatment with anticancer drugs and phosphatidylinositol
3-kinase inhibitors. Int J Oncol. 31:1141–1147. 2007.PubMed/NCBI
|
